Data vary regarding whether hypergastrinemia and proton pump inhibitor (PPI) use increase adenoma progression and risk of colorectal cancer (CRC). The current study from the
Long-Term Proton Pump Inhibitor
Long-Term Proton Pump Inhibitor
Strong Evidence That Long-Term Proton Pump Inhibitor Use Increases Colorectal Cancer Risk
Strong Evidence That Long-Term Proton Pump Inhibitor Use Increases Colorectal Cancer Risk
